Dr. John Bream posted a 2-minute youtube video on
Post# of 155368
(Total Views: 744)
Posted On: 03/30/2021 5:06:02 PM
Dr. John Bream posted a 2-minute youtube video on 3/28/21. I don't think he had any new information, but he is persistent about putting pressure on the FDA to approve. The video has only been viewed 1,424 times. The narrative below is the video description shown on the youtube page.
https://www.youtube.com/watch?v=KN02B6FOoRw
Dr. John Bream a Board Certified Emergency Room medicine Physician practicing in North Carolina talks about the benefits of a drug called Leronlimab by CytoDyn, a ccr5 receptor antagonist.
Dr. Bream stated, "put very simply the world needs Leronlimab to fight covid-19 at this point the pandemic.” Dr. Bream has seen hundreds if not thousands of patients with coronavirus and has admitted multiple patients to the hospital to die without any hope of a cure.
Once a patient becomes severely ill with covid-19 your options are essentially very limited including Decadron which only has a small reduction and mortality and possibly tocilizumab which is not widely available which also had a small reduction in mortality.
It is Dr. Bream's plea that Leronlimab be provided access to the market for covid-19. The recent phase 3 trial showed that when combined with Decadron the other standard of care drugs that the reduction in mortality was significant and that the length of stay for critically ill patients in the hospital with decreased by 6 days which helps decrease the backlog on the patients in the ICU care also significantly decreases the cost of care.
Leronlimab is up for emergency use authorization (EUA) at this time. Anything you can do to help support this life-changing life-saving molecule will be greatly appreciated. In addition, Leronlimab is being tried on patients suffering from longhaulers.
https://www.youtube.com/watch?v=KN02B6FOoRw
Dr. John Bream a Board Certified Emergency Room medicine Physician practicing in North Carolina talks about the benefits of a drug called Leronlimab by CytoDyn, a ccr5 receptor antagonist.
Dr. Bream stated, "put very simply the world needs Leronlimab to fight covid-19 at this point the pandemic.” Dr. Bream has seen hundreds if not thousands of patients with coronavirus and has admitted multiple patients to the hospital to die without any hope of a cure.
Once a patient becomes severely ill with covid-19 your options are essentially very limited including Decadron which only has a small reduction and mortality and possibly tocilizumab which is not widely available which also had a small reduction in mortality.
It is Dr. Bream's plea that Leronlimab be provided access to the market for covid-19. The recent phase 3 trial showed that when combined with Decadron the other standard of care drugs that the reduction in mortality was significant and that the length of stay for critically ill patients in the hospital with decreased by 6 days which helps decrease the backlog on the patients in the ICU care also significantly decreases the cost of care.
Leronlimab is up for emergency use authorization (EUA) at this time. Anything you can do to help support this life-changing life-saving molecule will be greatly appreciated. In addition, Leronlimab is being tried on patients suffering from longhaulers.
(5)
(0)